Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 108

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1A
Chunk 108
---
 10.10 of the Company’s Form 10-Q filed on August 13, 2024).
  
    14.1
     
    Code
    of Business Conduct and Ethics (incorporated by reference to Exhibit 14.1 to Form S-1 filed July 28, 2023).
  
    19.1
     
    Insider
    Trading Policy (incorporated by reference to Exhibit 99.5 to Form S-1 filed July 28, 2023).
  
    21.1
     
    List
    of Subsidiaries of Registrant (incorporated by reference to Exhibit 21.1 to Form S-1 filed July 28, 2023).
  
    23.1
     
    Consent of Cherry Bekaert LLP

    31.1*
     
    Certification
    of the Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant
    to Section 302 of the Sarbanes-Oxley Act of 2002
  
    31.2*
     
    Certification
    of the Interim Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as adopted
    pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  
    32.1**#
     
    Certification
    of the Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  
    32.2**#
     
    Certification
    of the Interim Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
    2002
  
    99.1
     
    Audit
    Committee Charter (incorporated by reference to Exhibit 99.1 to Form S-1 filed July 28, 2023).
  
    99.2
     
    Nominating
    and Corporate Governance Committee Charter (incorporated by reference to Exhibit 99.2 to Form S-1 filed July 28, 2023).
  
    99.3
     
    Compensation
    Committee